AVE 25.0% 0.3¢ avecho biotechnology limited

diabetics... a chance for life!

  1. 611 Posts.
    lightbulb Created with Sketch. 58
    Australia is giving diabetics a chance for life without the needle. This year, Melbourne Company Phosphagenics will conduct the second phase of human trials for a form of insulin that can be absorbed through the skin. For both type 1 and 2 diabetes sufferers, a slow-release insulin patch could cut the need for or even replace needles.

 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.